ImmunoCellular Therapeutics, Ltd to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 11th  
2/5/2013 6:09:00 AM

ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer of ImmunoCellular, will present a corporate overview and business update at the 15th Annual BIO CEO & Investor Conference on Monday, February 11, 2013 at 10:00 am ET at the Waldorf Astoria Hotel in New York City.